SCHEMBL31715976

SCHEMBL31715976

COc1ccc2nc(Cc3ccc(-c4cc(F)cc(F)c4)nc3)[nH]c(=O)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ ROCK2 O75116 4/20 0.46
▸ ROCK1 Q13464 2/20 0.43
▸ GRIN1 Q05586 2/20 0.43
▸ GRIN2B Q13224 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ TUBB4A P04350 2/20 0.42
▸ TUBB P07437 2/20 0.42
▸ TUBA3C P0DPH7 2/20 0.42
▸ TUBA1B P68363 2/20 0.42
▸ TUBA4A P68366 2/20 0.42
▸ TUBB4B P68371 2/20 0.42
▸ TUBB3 Q13509 2/20 0.42
▸ TUBB2A Q13885 2/20 0.42
▸ TUBB8 Q3ZCM7 2/20 0.42
▸ TUBA3E Q6PEY2 2/20 0.42
▸ TUBA1A Q71U36 2/20 0.42
▸ TUBA1C Q9BQE3 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31716946 0.85 LMNA (0.44) KDM4ELMNAROCK2PDE10A
SCHEMBL31717042 0.84 LMNA (0.43) KDM4ELMNAROCK2PDE10A
SCHEMBL31716955 0.84 LMNA (0.43) KDM4ELMNAROCK2
SCHEMBL31716050 0.84 LMNA (0.43) KDM4ELMNAROCK2
SCHEMBL31716882 0.83 MAPK1 (0.46) KDM4ELMNAROCK2PDE10A
SCHEMBL31715994 0.82 KDM4E (0.46) KDM4ELMNAROCK2
SCHEMBL31715980 0.82 LMNA (0.42) KDM4ELMNAROCK2PDE10A
SCHEMBL31716099 0.80 LMNA (0.41) KDM4ELMNAROCK2PDE10A
SCHEMBL31716260 0.79 PDE5A (0.36) KDM4ELMNAROCK2ROCK1TUBB4A
SCHEMBL31716584 0.77 KDM4E (0.60) KDM4ELMNAHSD17B10ROCK2GRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
Send feedback